Determination of Peripheral Neuropathy Prevalence and Associated Factors in Chinese Subjects with Diabetes and Pre-Diabetes - ShangHai Diabetic neuRopathy Epidemiology and Molecular Genetics Study (SH-DREAMS)

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Lu, Bin ^a   Hu, Ji ^b   Wen, Jian ^b   Zhang, Zhaoyun ^a   Zhou, Linuo ^a   Li, Yiming ^a,c   Hu, Renming ^a  

^a FUDAN UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c Shanghai Jing'an District Centre Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIPHERAL NEUROPATHY; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

BLOOD GLUCOSE; CHINA; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; GLUCOSE INTOLERANCE; HUMANS; INSULIN RESISTANCE; MALE; PERIPHERAL NERVOUS SYSTEM DISEASES; PREDIABETIC STATE; PREVALENCE;

EID: 84876196938     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061053     Document Type: Article

References (37)

1. Yang W, Lu J, Weng J, Jia W, Ji L, et al. (2010) Prevalence of Diabetes among Men and Women in China. N Engl J Med 362: 1090-1101.
2. Lu B, Yang Z, Wang M, Yang Z, Gong W, et al. (2010) High prevalence of diabetic neuropathy in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown. Diabetes Res Clin Pract 88: 289-294.
3. Lin Y, Xu Y, Chen G, Lai X, Huang B, et al. (2012) Diabetes and its chronic complications in the she ethnic minority group of China. Diabetes Technol Ther 14: 430-439.
4. Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A, (2009) Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg Surveys S2 and S3. Pain Med 10: 393-400.
5. Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A, (2008) Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care 31: 464-469.
6. Eriksson KF, Nilsson H, Lindgärde F, Osterlin S, Dahlin LB, et al. (1994) Diabetes mellitus but not impaired glucose tolerance is associated with dysfunction in peripheral nerves. Diabet Med 11: 279-285.
7. Singleton JR, Smith AG, Bromberg MB, (2001) Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 24: 1448-1453.
8. Novella SP, Inzucchi SE, Goldstein JM, (2001) The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve 24: 1229-1231.
9. Sahin S, Karsidag S, Ayalp S, Sengul A, Us O, (2009) Determination of nerve conduction abnormalities in patients with impaired glucose tolerance. Neurol Sci 30: 281-289.
10. Isak B, Oflazoglu B, Tanridag T, Yitmen I, Us O, (2008) Evaluation of peripheral and autonomic neuropathy among patients with newly diagnosed impaired glucose tolerance. Diabetes Metab Res Rev 24: 563-569.
11. Green AQ, Krishnan S, Finucane FM, Rayman G, (2010) Altered C-fiber function as an indicator of early peripheral neuropathy in individuals with impaired glucose tolerance. Diabetes Care 33: 174-176.
12. Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M, (2003) The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 60: 108-111.
13. Polydefkis M, Griffin JW, McArthur J, (2003) New insights into diabetic polyneuropathy. JAMA 290: 1371-1376.
14. Guidelines Subcommittee (1999) 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 17: 151-183.
15. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults, (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary. Am J Clin Nutr 68: 899-917.
16. American Diabetes Association, (2012) Diagnosis and classification of diabetes mellitus. Diabetes Care 35: S64-S71.
17. Cabezas-Cerrato J, (1998) The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups. Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS). Diabetologia 41: 1263-1269.
18. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH, (1993) A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36: 150-154.
19. Daousi C, MacFarlane IA, Woodward A, Nurmikko TJ, Bundred PE, et al. (2004) Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med 21: 976-982.
20. Harris MI, Hadden WC, Knowler WC, Bennett PH, (1987) Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in the US population age 20-74 years. Diabetes 36: 523-534.
21. Franklin GM, Kahn LB, Baxter J, Marshall JA, Hamman RF, (1990) Sensory neuropathy in non-insulin-dependent diabetes mellitus: the San Luis Valley Diabetes Study. Am J Epidemiol 131: 633-643.
22. de Neeling JN, Beks PJ, Bertelsmann FW, Heine RJ, Bouter LM, (1996) Peripheral somatic nerve function in relation to glucose tolerance in an elderly Caucasian population: the Hoorn study. Diabet Med 13: 960-966.
23. Putz Z, Tabák AG, Tóth N, Istenes I, Németh N, et al. (2009) Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance. Diabetes Care32: 181-183.
24. Jia WP, Shen Q, Bao YQ, Lu JX, Li M, et al. (2006) Evaluation of the four simple methods in the diagnosis of diabetic peripheral neuropathy. Natl Med J China 86: 2707-2710.
25. Bongaerts BW, Rathmann W, Kowall B, Herder C, Stöckl D, et al. (2012) Postchallenge hyperglycemia is positively associated with diabetic polyneuropathy: the KORA F4 study. Diabetes Care 35: 1891-1893.
26. Papanas N, Ziegler D (2012) Polyneuropathy in Impaired Glucose Tolerance: Is Postprandial Hyperglycemia the Main Culprit? A Mini-Review. Gerontology. 2012 Dec 1. [Epub ahead of print].
27. Smith AG, Singleton JR, (2008) Impaired glucose tolerance and neuropathy. Neurologist 14: 23-29.
28. Nguyen DV, Shaw LC, Grant MB, (2012) Inflammation in the pathogenesis of microvascular complications in diabetes. Front Endocrinol (Lausanne) 3: 170.
29. Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, et al. (2005) Vascular risk factors and diabetic neuropathy. N Engl J Med 352: 341-350.
30. Herman RM, Brower JB, Stoddard DG, Casano AR, Targov-nik JH, et al. (2007) Prevalence of somatic small fiber neuropathy in obesity. Int J Obes (Lond) 31: 226-235.
31. Gregg EW, Sorlie P, Paulose-Ram R, Gu Q, Eberhardt MS, et al. (2004) 1999-2000 national health and nutrition examination survey: Prevalence of lower-extremity disease in the U.S. adult population > = 40 years of age with and without diabetes: 1999-2000 National Health and Nutrition Examination Survey. Diabetes Care 27: 1591-1597.
32. Cheng YJ, Gregg EW, Kahn HS, Williams DE, De Rekeneire N, et al. (2006) Peripheral insensate neuropathy-a tall problem for US adults? Am J Epidemiol 164: 873-880.
33. Tapp RJ, Shaw JE, de Courten MP, Dun-stan DW, Welborn TA, et al. (2003) Foot complications in type 2 diabetes: an Australian population-based study. Diabet Med 20: 105-113.
34. Davies M, Brophy S, Williams R, Taylor A, (2006) The Prevalence, Severity, and Impact of Painful Diabetic Peripheral Neuropathy in Type 2 Diabetes. Diabetes Care 29: 1518-1522.
35. Dyck PJ, Clark VM, Overland CJ, Davies JL, Pach JM, et al. (2012) Impaired glycemia and diabetic polyneuropathy: the OC IG Survey. Diabetes Care 35: 584-591.
36. Liu F, Bao Y, Hu R, Zhang X, Li H, et al. (2010) Screening and prevalence of peripheral neuropathy in type 2 diabetic outpatients a randomized multicentre survey in 12 city hospitals of China. Diabetes Metab Res Rev 26: 481-489.
37. Kong AP, So WY, Szeto CC, Chan NN, Luk A, et al. (2006) Assessment of glomerular filtration rate in addition to albuminuria is important in managing type II diabetes. Kidney Int 69: 383-387.